The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model
Abstract
Background: Animal models that closely mimic clinical disease can be exploited to hasten the pace of translational research. To this end, we have defined windows of opportunity in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model of prostate cancer as a paradigm for designing pre‐clinical trials. Methods: The incidence of cancer, metastasis, and distribution of pathology were examined as a function of time in TRAMP mice. The expression of various markers of differentiation were characterized. Results: The TRAMP model develops progressive, multifocal, and heterogeneous disease. Each lobe of the prostate progressed at a different rate. Cytokeratin 8, E‐cadherin, and androgen receptor (AR) were expressed during cancer progression but levels were reduced or absent in late stage disease. A distinct epithelial to neuroendocrine (ENT) shift was observed to be a stochastic event related to prostate cancer progression in TRAMP. Conclusions: This study will serve as the basis for the rational design of pre‐clinical studies with genetically engineered mouse models. Prostate 55: 219–237, 2003. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.23 · Cited by 2,917
Gleason, D. F., Mellinger, G. T., & The Veterans Administration Cooperative Urological Research Group Members of this group areS0022534717598894-57c401330b4195dbd1713587ed540477 Lino J. Arduino Veterans Administration Center (VAC), D. M. (1974) · Journal of Urology · doi:10.1016/s0022-5347(17)59889-4 · Cited by 2,214
Prostate cancer in a transgenic mouse.
Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., & Rosen, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3439 · Cited by 1,294
Self-citationGittes, R. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101243240406 · Cited by 738
Metastatic prostate cancer in a transgenic mouse.
Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., & Greenberg, N. M. (1996) · PubMed · Cited by 599
Self-citationFoster, B. A., Gingrich, J. R., Kwon, E. D., Madias, C. A., & Greenberg, N. M. (1997) · PubMed · Cited by 489
Self-citationInhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols
Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S., & Mukhtar, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171326098 · Cited by 486
Androgen Receptor Localization in Different Cell Types of the Adult Rat Prostate*
PRINS, G. S., BIRCH, L., & GREENE, G. L. (1991) · Endocrinology · doi:10.1210/endo-129-6-3187 · Cited by 436
Hurwitz, A. A., Foster, B. A., Kwon, E. D., Truong, T. N., Choi, E. M., Greenberg, N. M., Burg, M. B., & Allison, J. P. (2000) · PubMed · Cited by 425
Self-citationCadherin switching in human prostate cancer progression.
Tomita, K., van Bokhoven, A., van Leenders, G. J. L. H., Ruijter, E. T. G., Jansen, C. F. J., Bussemakers, M. J. G., & Schalken, J. A. (2000) · PubMed · Cited by 425
Small Cell Lung Carcinoma (SCLC): A Clinicopathologic Study of 100 Cases With Surgical Specimens
Nicholson, S. A., Beasley, M. B., Brambilla, E., Hasleton, P. S., Colby, T. V., Sheppard, M. N., Falk, R., & Travis, W. D. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200209000-00009 · Cited by 395
Androgen-independent prostate cancer progression in the TRAMP model.
Gingrich, J. R., Barrios, R. J., Kattan, M. W., Nahm, H. S., Finegold, M. J., & Greenberg, N. M. (1997) · PubMed · Cited by 362
Self-citationHaploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
Kwabi-Addo, B., Giri, D., Schmidt, K., Podsypanina, K., Parsons, R., Greenberg, N., & Ittmann, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201167798 · Cited by 323
Self-citationCell differentiation lineage in the prostate
Wang, Y., Hayward, S. W., Cao, M., Thayer, K. A., & Cunha, G. R. (2001) · Differentiation · doi:10.1046/j.1432-0436.2001.680414.x · Cited by 304
Management of Cancer of the Prostate
Wood, A. J. J., & Catalona, W. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311507 · Cited by 294
Greenberg, N. M. (1994) · Molecular Endocrinology · doi:10.1210/me.8.2.230 · Cited by 267
Self-citationPathologic progression of autochthonous prostate cancer in the TRAMP model
Gingrich, Jr., Barrios, R., Foster, B., & Greenberg, N. (1999) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500296 · Cited by 253
Self-citationMentor-Marcel, R. A., Lamartiniere, C. A., Eltoum, I.-E. A., Greenberg, N. M., & Elgavish, A. (2001) · PubMed · Cited by 249
Self-citationAngiogenesis and prostate cancer: identification of a molecular progression switch.
Huss, W. J., Hanrahan, C. F., Barrios, R. J., Simons, J. W., & Greenberg, N. M. (2001) · PubMed · Cited by 234
Self-citationMasumori, N., Thomas, T. Z., Chaurand, P., Case, T. C., Paul, M., Kasper, S. F., Caprioli, R. M., Tsukamoto, T., Shappell, S. B., & Matusik, R. J. (2001) · PubMed · Cited by 228
Cox, M., Deeble, P. D., Lakhani, S., & Parsons, S. J. (1999) · PubMed · Cited by 224
Kaplan, P. J., Mohan, S., Cohen, P., Foster, B. A., & Greenberg, N. M. (1999) · PubMed · Cited by 215
Self-citationCadherin Switching in Human Prostate Cancer Progression
Schalken, J. A. (2000) · The Japanese Journal of Urology · doi:10.5980/jpnjurol.91.92 · Cited by 191
Deeble, P. D., Murphy, D. J., Parsons, S. J., & Cox, M. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8471-8482.2001 · Cited by 185
Mucci, N. R., Akdas, G., Manely, S., & Rubin, M. A. (2000) · Human Pathology · doi:10.1053/hp.2000.7295 · Cited by 182
A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells
Garabedian, E. M., Humphrey, P. A., & Gordon, J. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15382 · Cited by 177
E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.
Wechter, W. J., Leipold, D. D., Murray, E. D., Quiggle, D. D., McCracken, J. D., Barrios, R. J., & Greenberg, N. M. (2000) · PubMed · Cited by 164
Self-citationToremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.
Raghow, S., Hooshdaran, M. Z., Katiyar, S., et al. (2002) · PubMed · Cited by 155
Mouse models of prostate carcinogenesis
Abate-Shen, C. T., & Shen, M. M. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02683-5 · Cited by 145
Bonkhoff, H. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s141 · Cited by 145
Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
Gupta, S., Ahmad, N., Marengo, S. R., MacLennan, G. T., Greenberg, N. M., & Mukhtar, H. (2000) · PubMed · Cited by 126
Self-citationHan, G., Foster, B. A., Mistry, S. G., Buchanan, G., Harris, J. M., Tilley, W. D., & Greenberg, N. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008207200 · Cited by 123
Self-citationSegawa, N., Mori, I., Utsunomiya, H., Nakamura, M., Nakamura, Y., Shan, L., Kakudo, K., & Katsuoka, Y. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01226.x · Cited by 87
Prostate cancer progression, metastasis, and gene expression in transgenic mice.
Perez‐Stable, C., Altman, N. H., Mehta, P. P., Deftos, L. J., & Roos, B. A. (1997) · PubMed · Cited by 78
Raghow, S., Kuliyev, E., Steakley, M., Greenberg, N. M., & Steiner, M. S. (2000) · PubMed · Cited by 68
Self-citationMiyoshi, Y., Uemura, H., Kitami, K., Satomi, Y., Kubota, Y., & Hosaka, M. (2001) · British Journal of Urology · doi:10.1046/j.1464-4096.2001.00936.x · Cited by 57
LONGITUDINAL COHORT ANALYSIS OF LETHAL PROSTATE CANCER PROGRESSION IN TRANSGENIC MICE
HSU, C. X., Ross, B. D., Chrisp, C. E., DERROW, S. Z., Charles, L. G., Pienta, K. J., Greenberg, N. M., ZENG, Z., & Sanda, M. G. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62603-x · Cited by 54
Self-citationFoster, B., Kaplan, P., & Greenberg, N. (1999) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500297 · Cited by 36
Self-citation
Cited by
Molecular genetics of prostate cancer: new prospects for old challenges
Shen, M. M., & Abate-Shen, C. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 946
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Guerra, N., Tan, Y. X., Joncker, N. T., Choy, A., Gallardo, F., Xiong, N., Knoblaugh, S., Cado, D., Greenberg, N. R., & Raulet, D. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.016 · Cited by 850
Self-citationBettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G., & Corti, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1145 · Cited by 815
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shalapour, S., Font-Burgada, J., Di Caro, G., Zhong, Z., Sanchez-Lopez, E., Dhar, D., Willimsky, G., Ammirante, M., Strasner, A., Hansel, D. E., et al. (2015) · Nature · doi:10.1038/nature14395 · Cited by 611
Shappell, S. B., Thomas, G. V., Roberts, R. L., Herbert, R., Ittmann, M. M., Rubin, M. A., Humphrey, P. A., Sundberg, J. P., Rozengurt, N., Barrios, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0946 · Cited by 598
Self-citation
Metadata
- Authors
- Kaplan‐Lefko, P. J., Chen, T., Ittmann, M. M., Barrios, R. J., Ayala, G. E., Huss, W. J., Maddison, L. A., Foster, B. A., & Greenberg, N. M.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2003-04-07
- Volume
- 55
- Issue
- 3
- Pages
- 219-237
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2084541894
- Cited by
- 438
- References
- 38
- FWCI
- 19.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.